BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16081524)

  • 21. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
    Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
    Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
    Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
    Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
    Laughter AR; Dunn CS; Swanson CL; Howroyd P; Cattley RC; Corton JC
    Toxicology; 2004 Oct; 203(1-3):83-98. PubMed ID: 15363585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric assessment of peroxisome proliferation from frozen liver of fibrate-treated monkeys.
    Kwanyuen P; Witherspoon SM; Creech DR; Colton HM; Falls JG; Cariello NF
    Int J Toxicol; 2006; 25(1):41-7. PubMed ID: 16510356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.
    Nie W; Sweetser S; Rinella M; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G207-12. PubMed ID: 15458920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
    Yamazaki K; Kuromitsu J; Tanaka I
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
    Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
    Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.
    Xiao S; Anderson SP; Swanson C; Bahnemann R; Voss KA; Stauber AJ; Corton JC
    Toxicol Sci; 2006 Aug; 92(2):368-77. PubMed ID: 16687391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
    Lai DY
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo.
    Kane CD; Stevens KA; Fischer JE; Haghpassand M; Royer LJ; Aldinger C; Landschulz KT; Zagouras P; Bagley SW; Hada W; Dullea R; Hayward CM; Francone OL
    Mol Pharmacol; 2009 Feb; 75(2):296-306. PubMed ID: 18971326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine metabolic regulation in ruminants via nutrient-gene interactions: saturated long-chain fatty acids increase expression of genes involved in lipid metabolism and immune response partly through PPAR-α activation.
    Bionaz M; Thering BJ; Loor JJ
    Br J Nutr; 2012 Jan; 107(2):179-91. PubMed ID: 21729373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.
    Gonzalez FJ; Shah YM
    Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
    Woods CG; Kosyk O; Bradford BU; Ross PK; Burns AM; Cunningham ML; Qu P; Ibrahim JG; Rusyn I
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):267-77. PubMed ID: 17950772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.
    Misra P; Viswakarma N; Reddy JK
    Subcell Biochem; 2013; 69():77-99. PubMed ID: 23821144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of in vivo genotoxic potential of fenofibrate in rats subjected to two-week repeated oral administration.
    Tawfeeq MM; Suzuki T; Shimamoto K; Hayashi H; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Aug; 85(8):1003-11. PubMed ID: 21127841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.